Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study Evaluating the Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer - A Multicenter, Randomized, Open-label, Positive-controlled, Superiority Phase III Clinical Trial in China

NCT04185649 is registered in ClinicalTrials.gov with Bio-Thera Solutions as lead sponsor.

NCT NCT04185649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04185649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study Evaluating the Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer - A Multicenter, Randomized, Open-label, Positive-controlled, Superiority Phase III Clinical Trial in China
Lead sponsor
Bio-Thera Solutions
Phase
Phase 3
Overall status
Unknown status
Start date
July 1, 2018
Completion date
December 31, 2021
Enrollment
410 (estimated)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

her2-positive advanced breast cancer